a randomized crossover study between glargine U 300 and degludec in patients with type 1 diabetes
Not Applicable
Recruiting
- Conditions
- type 1 diabetes
- Registration Number
- JPRN-UMIN000019525
- Lead Sponsor
- Osaka City University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 35
Inclusion Criteria
Not provided
Exclusion Criteria
# pregnant # oral steroid therapy # advanced diabetes coomplication
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method